American Academy of Neurology (AAN), Neurology, 24(81), p. 2103-2106, 2013
DOI: 10.1212/01.wnl.0000437306.37850.22
Full text: Unavailable
We evaluated microRNAs (miRNAs) as potential biomarkers for Alzheimer disease (AD) by analyzing the expression level of miRNAs in CSF of patients with AD dementia and nonaffected control subjects.